Literature DB >> 3422754

Expression of the firefly luciferase gene in vaccinia virus: a highly sensitive gene marker to follow virus dissemination in tissues of infected animals.

J F Rodriguez1, D Rodriguez, J R Rodriguez, E B McGowan, M Esteban.   

Abstract

We have introduced the firefly luciferase gene of Photinus pyralis into the vaccinia virus genome. This gene is expressed in a coordinate fashion during virus infection. Luminescence produced by the action of luciferase [Photinus-luciferin:oxygen 4-oxidoreductase(decarboxylating, ATP-hydrolyzing), EC 1.13.12.7] was easily detectable in infected cells in culture as well as in cells of tissues of infected mice. The limits of detection were about one infected cell in a background of a million noninfected cells. The luciferase assay was about 1000-fold more sensitive than that of beta-galactosidase. Our findings show that the luciferase assay can be conveniently used to follow viral gene expression and virus dissemination both in cell cultures and in tissues of infected animals.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3422754      PMCID: PMC279835          DOI: 10.1073/pnas.85.5.1667

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  The purification fo four strains of poxvirus.

Authors:  W K JOKLIK
Journal:  Virology       Date:  1962-09       Impact factor: 3.616

2.  A 14K envelope protein of vaccinia virus with an important role in virus-host cell interactions is altered during virus persistence and determines the plaque size phenotype of the virus.

Authors:  S Dallo; J F Rodriguez; M Esteban
Journal:  Virology       Date:  1987-08       Impact factor: 3.616

3.  Virus attenuation and identification of structural proteins of vaccinia virus that are selectively modified during virus persistence.

Authors:  E Paez; S Dallo; M Esteban
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

Review 4.  Vaccinia virus expression vectors.

Authors:  M Mackett; G L Smith
Journal:  J Gen Virol       Date:  1986-10       Impact factor: 3.891

5.  In vitro mutagenesis of the promoter region for a vaccinia virus gene: evidence for tandem early and late regulatory signals.

Authors:  M A Cochran; C Puckett; B Moss
Journal:  J Virol       Date:  1985-04       Impact factor: 5.103

6.  Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype.

Authors:  R M Buller; G L Smith; K Cremer; A L Notkins; B Moss
Journal:  Nature       Date:  1985 Oct 31-Nov 6       Impact factor: 49.962

7.  Firefly luciferase is targeted to peroxisomes in mammalian cells.

Authors:  G A Keller; S Gould; M Deluca; S Subramani
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

8.  Isolation and characterization of attenuated mutants of vaccinia virus.

Authors:  S Dallo; M Esteban
Journal:  Virology       Date:  1987-08       Impact factor: 3.616

9.  Cloning of firefly luciferase cDNA and the expression of active luciferase in Escherichia coli.

Authors:  J R de Wet; K V Wood; D R Helinski; M DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

10.  Firefly luciferase gene: structure and expression in mammalian cells.

Authors:  J R de Wet; K V Wood; M DeLuca; D R Helinski; S Subramani
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

View more
  52 in total

1.  Attenuated modified vaccinia virus Ankara can be used as an immunizing agent under conditions of preexisting immunity to the vector.

Authors:  J C Ramírez; M M Gherardi; D Rodríguez; M Esteban
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  Inhibition of host translation by virus infection in vivo.

Authors:  René Toribio; Iván Ventoso
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

3.  Blocking HIV-1 infection via CCR5 and CXCR4 receptors by acting in trans on the CCR2 chemokine receptor.

Authors:  José Miguel Rodríguez-Frade; Gustavo del Real; Antonio Serrano; Patricia Hernanz-Falcón; Silvia F Soriano; Antonio J Vila-Coro; Ana Martín de Ana; Pilar Lucas; Ignacio Prieto; Carlos Martínez-A; Mario Mellado
Journal:  EMBO J       Date:  2003-12-11       Impact factor: 11.598

Review 4.  Molecular biology of bacterial bioluminescence.

Authors:  E A Meighen
Journal:  Microbiol Rev       Date:  1991-03

Review 5.  Applications of bioluminescence imaging to antiviral research and therapy: multiple luciferase enzymes and quantitation.

Authors:  Kathryn E Luker; Gary D Luker
Journal:  Antiviral Res       Date:  2008-03-05       Impact factor: 5.970

6.  Kinetics of recombinant adenovirus type 5, vaccinia virus, modified vaccinia ankara virus, and DNA antigen expression in vivo and the induction of memory T-lymphocyte responses.

Authors:  Ralf Geiben-Lynn; John R Greenland; Kwesi Frimpong-Boateng; Norman L Letvin
Journal:  Clin Vaccine Immunol       Date:  2008-02-13

7.  Highly sensitive real-time in vivo imaging of an influenza reporter virus reveals dynamics of replication and spread.

Authors:  Vy Tran; Lindsey A Moser; Daniel S Poole; Andrew Mehle
Journal:  J Virol       Date:  2013-10-02       Impact factor: 5.103

8.  Detection of a single genetically modified bacterial cell in soil by using charge coupled device-enhanced microscopy.

Authors:  D J Silcock; R N Waterhouse; L A Glover; J I Prosser; K Killham
Journal:  Appl Environ Microbiol       Date:  1992-08       Impact factor: 4.792

9.  A single transcription factor binds to two divergent sequence elements with a common function in cardiac myosin light chain-2 promoter.

Authors:  P Qasba; E Lin; M D Zhou; A Kumar; M A Siddiqui
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

10.  Expression of the E3L gene of vaccinia virus in transgenic mice decreases host resistance to vaccinia virus and Leishmania major infections.

Authors:  Elena Domingo-Gil; Eva Pérez-Jiménez; Iván Ventoso; José L Nájera; Mariano Esteban
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.